Recent Material Events - Aeolus Pharmaceuticals, Inc. (AOLS)

Filing Date	Description
2008-05-09	On May 9, 2008, Aeolus Pharmaceuticals, Inc. issued an earnings release to announce its earnings for the three and six months ended March 31, 2008. ...
2008-04-08	Statements in the preceding paragraphs and all other statements that are not strictly historical are “forward-looking” and involve a high degree of risk and uncertainty. These statements include, but are not limited to, those related to: ...
2008-04-03	Reference is made to Item 1.01 of this report for a description of an agreement between the Company and UBS Financial Services regarding the Margin Agreement. ...
2008-02-06	On February 6, 2008, Aeolus Pharmaceuticals, Inc. issued an earnings release to announce its earnings for the three months ended December 31, 2007. ...
2007-12-13	Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, or a non-accelerated filer. ...
2007-12-13	On December 13, 2007, Aeolus Pharmaceuticals, Inc. issued an earnings release to announce its earnings for the three months and twelve months ended September 30, 2007. ...
2007-11-07	On November 5, 2007, Aeolus Pharmaceuticals, Inc. (“Aeolus”) provided an update on its drug development program and on November 7, 2007, Aeolus reported results of a pre-clinical study of AEOL 10150 for the treatment of mustard gas e ...
2007-02-09	On February 9, 2007, Aeolus Pharmaceuticals, Inc. issued an earnings release to announce its earnings for the three months ended December 31, 2006.... ...
2006-12-15	On December 15, 2006, Aeolus Pharmaceuticals, Inc. issued an earnings release to announce its earnings for the three months and twelve months ended September 30, 2006.... ...
2006-12-07	(b) As a result of the decision by Aeolus Pharmaceuticals, Inc. (“Aeolus” or the “Company”) to change its strategic direction to focus on the clinical development of AEOL 10150 as a protector of healthy normal cells in radi... ...